News
LaMontagne will lead the commercial rollout of the company’s groundbreaking early-stage cancer detection test, Certitude.
Data from the 2021 National Health Interview Survey showed racial/ethnic differences in colorectal cancer screening were due to demographic and socioeconomic factors, except for low colonoscopy use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results